Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole
Nolan Wood(Certara (United States)), D. J. Nichols(Pfizer (United Kingdom)), Lynn Purkins(Ziarco (United Kingdom)), Diane Kleinermans(Erasmus Hospital), Julia Hamlin(Pfizer (United Kingdom)), Gary Layton(University of Geneva), Keith Tan(Pfizer (United Kingdom))
Cited by 105
Related Papers
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2014|488
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
|Circulation|2011|375
Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
|CHEST Journal|2011|257
STARTS-2
|Circulation|2014|212